The energetics of Huntington's disease

被引:190
作者
Browne, SE [1 ]
Beal, MF [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
关键词
Huntington's disease; Huntingtin mitochondria; energy metabolism; glucose utilization; genetic models;
D O I
10.1023/B:NERE.0000014824.04728.dd
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is a hereditary neurodegenerative disorder that gradually robs sufferers of the ability to control movements and induces psychological and cognitive impairments. This devastating, lethal disease is one of several neurological disorders caused by trinucleotide expansions in affected genes, including spinocerebellar ataxias, dentatorubralpallidoluysian atrophy, and spinal bulbar muscular atrophy. HD symptoms are associated with region-specific neuronal loss within the central nervous system, but to date the mechanism of this selective cell death remains unknown. Strong evidence from studies in humans and animal models suggests the involvement of energy metabolism defects, which may contribute to excitotoxic processes, oxidative dmage, and altered gene regulation. The development of transgenic mouse models expressing the human HD mutation has provided novel opportunities to explore events underlying selective neuronal death in HD, which has hitherto been impossible in humans. Here we discuss how animal models are redefining the role of energy metabolism in HD etiology.
引用
收藏
页码:531 / 546
页数:16
相关论文
共 144 条
[91]   Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1 [J].
Mastrogiacomo, F ;
LaMarche, J ;
Dozic, S ;
Lindsay, G ;
Bettendorff, L ;
Robitaille, Y ;
Schut, L ;
Kish, SJ .
NEURODEGENERATION, 1996, 5 (01) :27-33
[92]  
Matsuishi T, 1996, ACTA NEUROL SCAND, V93, P72
[93]  
Matthews RT, 1998, J NEUROSCI, V18, P156
[94]   Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts [J].
Mazzola, JL ;
Sirover, MA .
MOLECULAR BRAIN RESEARCH, 2002, 100 (1-2) :95-101
[95]   Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts [J].
Mazzola, JL ;
Sirover, MA .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (02) :442-449
[96]   Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice [J].
Meade, CA ;
Deng, YP ;
Fusco, FR ;
Del Mar, N ;
Hersch, S ;
Goldowitz, D ;
Reiner, A .
JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 449 (03) :241-269
[97]   CSF AND SERUM METABOLIC PROFILE OF PATIENTS WITH HUNTINGTONS-CHOREA - A STUDY BY HIGH-RESOLUTION PROTON NMR-SPECTROSCOPY AND HPLC [J].
NICOLI, F ;
VIONDURY, J ;
MALOTEAUX, JM ;
DELWAIDE, C ;
CONFORTGOUNY, S ;
SCIAKY, M ;
COZZONE, PJ .
NEUROSCIENCE LETTERS, 1993, 154 (1-2) :47-51
[98]   GLUTAMATE BECOMES NEUROTOXIC VIA THE N-METHYL-D-ASPARTATE RECEPTOR WHEN INTRACELLULAR ENERGY-LEVELS ARE REDUCED [J].
NOVELLI, A ;
REILLY, JA ;
LYSKO, PG ;
HENNEBERRY, RC .
BRAIN RESEARCH, 1988, 451 (1-2) :205-212
[99]  
OBRIEN CF, 1990, ANN NEUROL, V28, P300
[100]   Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines [J].
Panov, AV ;
Gutekunst, CA ;
Leavitt, BR ;
Hayden, MR ;
Burke, JR ;
Strittmatter, WJ ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2002, 5 (08) :731-736